GSK plc (GLAXF) Financials

GLAXF Assets vs Liabilities

DateAssetsLiabilities
Sept. 30, 2026 95.6 billion 71.1 billion
June 30, 2026 81.2 billion 58.6 billion
March 31, 2026 83.0 billion 60.0 billion
Dec. 31, 2025 82.1 billion 60.6 billion

GLAXF Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2026 3.1 billion ?
June 30, 2026 2.9 billion ?
March 31, 2026 921.4 million ?
Dec. 31, 2025 2.0 billion ?

GLAXF Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
Sept. 30, 2026 2.0 billion
June 30, 2026 572.1 million
March 31, 2026 2.4 billion
Dec. 31, 2025 854.5 million

GLAXF Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2026 3.9 billion 28.9 billion -
June 30, 2026 4.1 billion 18.3 billion -
March 31, 2026 4.5 billion 18.5 billion -
Dec. 31, 2025 4.6 billion 19.8 billion 1.1 billion

GLAXF Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2026 5.4 billion
June 30, 2026 5.4 billion
March 31, 2026 5.4 billion
Dec. 31, 2025 5.5 billion

GLAXF Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2026 485.6 million 2.4 billion 3.2 billion -
June 30, 2026 431.4 million 2.3 billion 2.9 billion -
March 31, 2026 584.8 million 2.2 billion 2.8 billion -
Dec. 31, 2025 769.9 million 3.1 billion 3.6 billion -

GLAXF Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2026 11.5 billion 2.9 billion
June 30, 2026 11.1 billion 2.7 billion
March 31, 2026 10.1 billion 2.5 billion
Dec. 31, 2025 11.6 billion 3.5 billion

GLAXF

Price: $23.40

52 week price:
20.80
31.48

Dividend Yield: 3.18%

5-year range yield:
3.18%
182.12%

Payout Ratio: 51.48%

Payout Ratio Range:
-1055.17%
938.88%

Earnings Per Share: 1.42 USD

P/E Ratio: 16.04

Exchange: PNK

Sector: Healthcare

Industry: Drug Manufacturers - General

Country: United Kingdom

Market Capitalization: 91.2 billion

Average Dividend Frequency: 8

Years Paying Dividends: 23

DGR3: 19.79%

DGR5: 8.56%

DGR10: 2.50%

DGR20: 7.16%

Links: